Clinical Trial Update: Safety Study of a Plant-based H5 Virus-Like Particles (VLP) Vaccine in Healthy Adults [Phase 1]

View source ↗

Summary

A Phase 1 safety study of a plant-based influenza A H5 virus-like particle vaccine was completed in healthy adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Infection

Drugs mentioned

• Plant-based H5 influenza virus-like particle vaccine (Influenza A H5 virus-like particle vaccine (plant-based))

Snippet

Sponsor: Medicago | Conditions: Virus Diseases, RNA Virus Infections | Phase 1 | Status: COMPLETED